Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2008-11-17
pubmed:abstractText
Determining which patients benefit from larynx preservation strategies remains problematic. We reviewed our experience using multiagent concurrent chemoradiotherapy to identify clinical predictors for success.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1097-0347
pubmed:author
pubmed:copyrightInfo
(c) 2008 Wiley Periodicals, Inc.
pubmed:issnType
Electronic
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1535-42
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18704968-Adult, pubmed-meshheading:18704968-Aged, pubmed-meshheading:18704968-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18704968-Chemotherapy, Adjuvant, pubmed-meshheading:18704968-Cisplatin, pubmed-meshheading:18704968-Female, pubmed-meshheading:18704968-Fluorouracil, pubmed-meshheading:18704968-Humans, pubmed-meshheading:18704968-Hypopharyngeal Neoplasms, pubmed-meshheading:18704968-Kaplan-Meier Estimate, pubmed-meshheading:18704968-Laryngeal Neoplasms, pubmed-meshheading:18704968-Laryngectomy, pubmed-meshheading:18704968-Male, pubmed-meshheading:18704968-Middle Aged, pubmed-meshheading:18704968-Neoplasms, Squamous Cell, pubmed-meshheading:18704968-Patient Participation, pubmed-meshheading:18704968-Patient Selection, pubmed-meshheading:18704968-Radiotherapy, Adjuvant, pubmed-meshheading:18704968-Retrospective Studies, pubmed-meshheading:18704968-Survival Analysis, pubmed-meshheading:18704968-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
pubmed:affiliation
Cleveland Clinic, Taussig Cancer Center, Cleveland, Ohio, USA. rodrigc@ccf.org
pubmed:publicationType
Journal Article